APRIL/MAY 2009 VOLUME 2, NUMBER 3

AHDB is included in the following indexing and database services: Cumulative Index to Nursing and Allied Health Literature (CINAHL) EBSCOhost research databases (EBSCO)

Editorial                                                                  
The Paradox of Public Policy Reform: Change or Continuum?
By Robert E. Henry
This is shaping up to be a watershed year for public health reform. Pressures of cost, quality, and access...
FULL ARTICLE

Are You Kidding Me? Clinical Comparative Effectiveness
or Evidence-Based Medicine
By Thomas Kaye RPh, MBA, FASHP
The hand-selected federal Council for Comparative Effectiveness Research includes no pharmacists or drug experts...
FULL ARTICLE

REGULATORY                                                            
MIPPA: First Broad Changes to Medicare
Part D Plan Operations
By Jean D. LeMasurier; Babette Edgar, PharmD, MBA
MIPPA includes the first broad legislative changes to Medicare Part D, with changes directly affecting drug benefit design…
FULL ARTICLE
Stakeholder Perspective by Mark Newsom, MSc

Clinical                                                                     
ProvenCare: Geisinger’s Model for Care Transformation through Innovative Clinical Initiatives and Value Creation
Interview with Ronald A. Paulus, MD, MBA
A key component of Geisinger’s approach is an innovative model of incentives for the consumer, the provider, and the payer…
FULL ARTICLE

Perspective: The Integrated Patient-Centered Medical Home: Tools for Transforming Our Healthcare Delivery System
By Matias A. Klein
The patient-centered medical home has the potential to enhance the US healthcare system by…
FULL ARTICLE

Business                                                                   
Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers
By Melinda C. Haren, RN; Kirk McConnell; Arthur F. Shinn, PharmD, FASCP
Growth in healthcare costs is inevitable, but the current trend of cost-shifting to plan members is unsustainable...
FULL ARTICLE
Stakeholder Perspective by Paul Anthony Polansky, BSPharm, MBA

Generic Drug Trends                                          
New Legislations on Generics and Biosimilars Brewing in Congress
By Dalia Buffery, MA, ABD
Several bills introduced in Congress in March involve generics and biosimilars…
FULL ARTICLE

Industry Trends                                                    
Paying for Cancer Care: Economic Models Start to Emerge, Dovetailing Healthcare Reform
By Caroline Helwick
In this economic climate, the financial framework for cancer care is headed for change, but how?…
FULL ARTICLE